Skip to main content
Bluvy Tube
Press Esc to exit fullscreen
Volume m
/
i
Theater mode t
f
/
NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life. • 6.1% of 1.8M patients in one US system had a genetic test on file • ~99% of US veterans carry ≥1 actionable drug-response variant • genotype-guided prescribing: 30% fewer adverse reactions (RCT) #MedSky #Genomics

Keyboard shortcuts

Space K
Play / pause
← →
Back / forward 5 s
J L
Back / forward 10 s
0–9
Jump to 0%–90% of the video
Home End
Start / end
, .
Previous / next frame (while paused)
< >
Slower / faster
↑ ↓
Volume
M
Mute / unmute
C
Captions
F
Fullscreen
I
Picture-in-picture
T
Theater mode
?
Show this help

NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life. • 6.1% of 1.8M patients in one US system had a genetic test on file • ~99% of US veterans carry ≥1 actionable drug-response variant • genotype-guided prescribing: 30% fewer adverse reactions (RCT) #MedSky #Genomics

Dr. Dimitar Georgiev

Dr. Dimitar Georgiev

@drdimitargeorgiev.bsky.social

Subscribe
0 views Published on 17/11/2026 10:27 0:22
#medsky #genomics
NEJM review (Hunter & Inouye, 2026): a genome sequenced once could serve for life. • 6.1% of 1.8M patients in one US system had a genetic test on file • ~99% of US veterans carry ≥1 actionable drug-response variant • genotype-guided prescribing: 30% fewer adverse reactions (RCT) #MedSky #Genomics
1 comment
?
Animated summary of the key numbers (on-screen text in Bulgarian). Full review: doi.org/10.1056/NEJMra2413201
View original post on Bluesky
Link copied to clipboard

Sign in

Time to take a break

You've been watching videos for 30 minutes straight: give yourself 5 minutes away from the screen. Stand up, stretch, grab a glass of water… Your videos will be right here when you're back.